145 related articles for article (PubMed ID: 32827460)
1. A Functional Screening Strategy for Engineering Chimeric Antigen Receptors with Reduced On-Target, Off-Tumor Activation.
Di Roberto RB; Castellanos-Rueda R; Frey S; Egli D; Vazquez-Lombardi R; Kapetanovic E; Kucharczyk J; Reddy ST
Mol Ther; 2020 Dec; 28(12):2564-2576. PubMed ID: 32827460
[TBL] [Abstract][Full Text] [Related]
2. Scrutiny of chimeric antigen receptor activation by the extracellular domain: experience with single domain antibodies targeting multiple myeloma cells highlights the need for case-by-case optimization.
Hanssens H; Meeus F; De Vlaeminck Y; Lecocq Q; Puttemans J; Debie P; De Groof TWM; Goyvaerts C; De Veirman K; Breckpot K; Devoogdt N
Front Immunol; 2024; 15():1389018. PubMed ID: 38720898
[TBL] [Abstract][Full Text] [Related]
3. T Cell Activation Machinery: Form and Function in Natural and Engineered Immune Receptors.
Chandler NJ; Call MJ; Call ME
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33050044
[TBL] [Abstract][Full Text] [Related]
4. Humanized single-domain antibody targeting HER2 enhances function of chimeric antigen receptor T cells.
Zheng R; Chen Y; Zhang Y; Liang S; Zhao X; Wang Y; Wang P; Meng R; Yang A; Yan B
Front Immunol; 2023; 14():1258156. PubMed ID: 38022548
[TBL] [Abstract][Full Text] [Related]
5. Breaking Bottlenecks for the TCR Therapy of Cancer.
Gaissmaier L; Elshiaty M; Christopoulos P
Cells; 2020 Sep; 9(9):. PubMed ID: 32937956
[TBL] [Abstract][Full Text] [Related]
6. CAR T cells produced in vivo to treat cardiac injury.
Rurik JG; Tombácz I; Yadegari A; Méndez Fernández PO; Shewale SV; Li L; Kimura T; Soliman OY; Papp TE; Tam YK; Mui BL; Albelda SM; Puré E; June CH; Aghajanian H; Weissman D; Parhiz H; Epstein JA
Science; 2022 Jan; 375(6576):91-96. PubMed ID: 34990237
[TBL] [Abstract][Full Text] [Related]
7. Engineering chimeric antigen receptor neutrophils from human pluripotent stem cells for targeted cancer immunotherapy.
Chang Y; Syahirah R; Wang X; Jin G; Torregrosa-Allen S; Elzey BD; Hummel SN; Wang T; Li C; Lian X; Deng Q; Broxmeyer HE; Bao X
Cell Rep; 2022 Jul; 40(3):111128. PubMed ID: 35858579
[TBL] [Abstract][Full Text] [Related]
8. Hyperstabilization of T cell microvilli contacts by chimeric antigen receptors.
Beppler C; Eichorst J; Marchuk K; Cai E; Castellanos CA; Sriram V; Roybal KT; Krummel MF
J Cell Biol; 2023 Mar; 222(3):. PubMed ID: 36520493
[TBL] [Abstract][Full Text] [Related]
9. Discovery of internalizing antibodies to basal breast cancer cells.
Zhou Y; Zou H; Yau C; Zhao L; Hall SC; Drummond DC; Farr-Jones S; Park JW; Benz CC; Marks JD
Protein Eng Des Sel; 2018 Jan; 31(1):17-28. PubMed ID: 29301020
[TBL] [Abstract][Full Text] [Related]
10. Use of Cell and Genome Modification Technologies to Generate Improved "Off-the-Shelf" CAR T and CAR NK Cells.
Morgan MA; Büning H; Sauer M; Schambach A
Front Immunol; 2020; 11():1965. PubMed ID: 32903482
[TBL] [Abstract][Full Text] [Related]
11. CAR-expressing NK cells for cancer therapy: a new hope.
Xia J; Minamino S; Kuwabara K
Biosci Trends; 2020 Nov; 14(5):354-359. PubMed ID: 32893255
[TBL] [Abstract][Full Text] [Related]
12. CRISPR/Cas9-Engineered Universal CD19/CD22 Dual-Targeted CAR-T Cell Therapy for Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia.
Hu Y; Zhou Y; Zhang M; Ge W; Li Y; Yang L; Wei G; Han L; Wang H; Yu S; Chen Y; Wang Y; He X; Zhang X; Gao M; Yang J; Li X; Ren J; Huang H
Clin Cancer Res; 2021 May; 27(10):2764-2772. PubMed ID: 33627493
[TBL] [Abstract][Full Text] [Related]
13. Deletion of Cbl-b inhibits CD8
Kumar J; Kumar R; Kumar Singh A; Tsakem EL; Kathania M; Riese MJ; Theiss AL; Davila ML; Venuprasad K
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33462140
[TBL] [Abstract][Full Text] [Related]
14. CRISPR/Cas: From Tumor Gene Editing to T Cell-Based Immunotherapy of Cancer.
Azangou-Khyavy M; Ghasemi M; Khanali J; Boroomand-Saboor M; Jamalkhah M; Soleimani M; Kiani J
Front Immunol; 2020; 11():2062. PubMed ID: 33117331
[TBL] [Abstract][Full Text] [Related]
15. Monitoring CAR T cell generation with a CD8-targeted lentiviral vector by single-cell transcriptomics.
Charitidis FT; Adabi E; Thalheimer FB; Clarke C; Buchholz CJ
Mol Ther Methods Clin Dev; 2021 Dec; 23():359-369. PubMed ID: 34729382
[TBL] [Abstract][Full Text] [Related]
16. PTK7-Targeting CAR T-Cells for the Treatment of Lung Cancer and Other Malignancies.
Jie Y; Liu G; Feng L; Li Y; E M; Wu L; Li Y; Rong G; Li Y; Wei H; Gu A
Front Immunol; 2021; 12():665970. PubMed ID: 34475869
[TBL] [Abstract][Full Text] [Related]
17. The immunostimulatory RNA RN7SL1 enables CAR-T cells to enhance autonomous and endogenous immune function.
Johnson LR; Lee DY; Eacret JS; Ye D; June CH; Minn AJ
Cell; 2021 Sep; 184(19):4981-4995.e14. PubMed ID: 34464586
[TBL] [Abstract][Full Text] [Related]
18. Leveraging Single-Cell Sequencing for Chimeric Antigen Receptor T Cell Therapies.
Castellanos-Rueda R; Di Roberto RB; Schlatter FS; Reddy ST
Trends Biotechnol; 2021 Dec; 39(12):1308-1320. PubMed ID: 33832782
[TBL] [Abstract][Full Text] [Related]
19. A Critical Role for Fas-Mediated Off-Target Tumor Killing in T-cell Immunotherapy.
Upadhyay R; Boiarsky JA; Pantsulaia G; Svensson-Arvelund J; Lin MJ; Wroblewska A; Bhalla S; Scholler N; Bot A; Rossi JM; Sadek N; Parekh S; Lagana A; Baccarini A; Merad M; Brown BD; Brody JD
Cancer Discov; 2021 Mar; 11(3):599-613. PubMed ID: 33334730
[TBL] [Abstract][Full Text] [Related]
20. Deep mutational scanning of proteins in mammalian cells.
Maes S; Deploey N; Peelman F; Eyckerman S
Cell Rep Methods; 2023 Nov; 3(11):100641. PubMed ID: 37963462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
